צפורוקסים מדו 750 מ"ג - Cefuroxime medo 750 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× |
|
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | J01DC Second-generation cephalosporins |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ת××-שר×ר×, ת××-×ר××× - I.M, I.V |
| צ×רת ××× ×× | ×××§× ××××¡× ×××רק×\××× ×¤××××, POWDER FOR SOLUTION FOR INJ/INF ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | Cefuroxime Medo is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)⢠Community acquired pneumonia⢠Acute exacerbations of chronic bronchitis⢠Complicated urinary tract infections, including pyelonephritis⢠Soft-tissue infections: cellulitis, erysipelas and wound infections⢠Intra-abdominal infections ⢠Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section) ⢠nose infections for example, sinusitis ⢠septic arthritis |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| צפ×ר×קס×× ××× 750 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | MEDOCHEMIE LTD (FACTORY C), CYPRUS |
| ×©× ××¢× ×ר×ש×× | A.L. MEDI-MARKET LTD. |
| ר×ש××× | ת×ר×× ××ש×: 2/2019. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | {{{ת×ר×× ×¢××××}}} |
השינוי האחרון נעשה בֹ־24 בפברואר 2024 ב־03:07